Study of microRNAs as a Diagnostic Tool for HCV-related Hepatocellular Carcinoma
NCT03429530 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-02-12
Summary
The aim of this work is to study the role of circulating miRNAs in diagnosis of HCV related hepatocellular carcinoma.
Conditions
- miRna in HCC
Sponsors & Collaborators
-
HMHamed
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-15
- Primary Completion
- 2019-02-28
- Completion
- 2019-03-31
More Related Trials
-
HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation
NCT04455932 ·Status: RECRUITING ·Phase: NA
-
A Nomogram for Evaluating Significant Liver Fibrosis in Patients With Chronic Hepatitis B Virus Infection
NCT05560503 ·Status: COMPLETED
-
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
NCT01034865 ·Status: COMPLETED
-
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
NCT03804593 ·Status: COMPLETED
-
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
NCT04288323 ·Status: COMPLETED ·Phase: PHASE4
-
Prognostic Models for HCC Based on Tumor Micronecrosis
NCT05837065 ·Status: UNKNOWN
-
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002 ·Status: UNKNOWN
-
Clinical Trial Multi-analyte Blood Test
NCT03694600 ·Status: UNKNOWN
-
Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test
NCT03493763 ·Status: UNKNOWN
-
Characteristic and Survival Outcomes in Hepatocellular Carcinoma Patients: on Top of Viral Hepatitis Versus Combined Viral and Metabolic-Associated Steatotic Liver Disease
NCT06871930 ·Status: NOT_YET_RECRUITING
-
Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular Carcinoma
NCT03892681 ·Status: UNKNOWN ·Phase: NA
-
Abbreviated MRI for HCC Surveillance
NCT03731923 ·Status: UNKNOWN ·Phase: NA
-
Harms of Hepatocellular Carcinoma Surveillance
NCT03756051 ·Status: COMPLETED
-
GastrOesophageal Varices After Sustained Virological Response
NCT04191018 ·Status: UNKNOWN
-
Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]
NCT02514434 ·Status: UNKNOWN ·Phase: NA
-
To Study the Effects of Host Genetic Factors on Liver Cirrhosis and Hepatocellular Carcinoma (HCC)
NCT00709085 ·Status: UNKNOWN
-
Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic Cholangiocarcinoma
NCT05327907 ·Status: UNKNOWN
-
Pretreatment Lymphocyte Monocyte Ratio on Outcome HCC Patients
NCT03869151 ·Status: UNKNOWN
-
Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease
NCT01350167 ·Status: UNKNOWN ·Phase: NA
-
Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.
NCT06899854 ·Status: RECRUITING
-
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
NCT07147335 ·Status: RECRUITING
-
Evaluation of Patients With Liver Disease
NCT00001971 ·Status: RECRUITING
-
A Worldwide Score for Hepatocellular Cancer and Liver Transplantation
NCT03595345 ·Status: COMPLETED
-
The Utility of Breath Biopsy as a Screening Tool for HCC
NCT04326491 ·Status: COMPLETED
-
HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC
NCT03020342 ·Status: UNKNOWN